KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Ionis Pharmaceuticals (IONS) Receivables - Other (2016 - 2025)

Ionis Pharmaceuticals has reported Receivables - Other over the past 17 years, most recently at $66.1 million for Q4 2025.

  • Quarterly results put Receivables - Other at $66.1 million for Q4 2025, down 28.34% from a year ago — trailing twelve months through Dec 2025 was $66.1 million (down 28.34% YoY), and the annual figure for FY2025 was $66.1 million, down 28.34%.
  • Receivables - Other for Q4 2025 was $66.1 million at Ionis Pharmaceuticals, up from $24.6 million in the prior quarter.
  • Over the last five years, Receivables - Other for IONS hit a ceiling of $142.4 million in Q3 2023 and a floor of $5.1 million in Q1 2024.
  • Median Receivables - Other over the past 5 years was $25.8 million (2022), compared with a mean of $39.5 million.
  • Biggest five-year swings in Receivables - Other: surged 2042.35% in 2023 and later tumbled 87.41% in 2024.
  • Ionis Pharmaceuticals' Receivables - Other stood at $61.9 million in 2021, then plummeted by 58.74% to $25.5 million in 2022, then surged by 282.87% to $97.8 million in 2023, then dropped by 5.72% to $92.2 million in 2024, then decreased by 28.34% to $66.1 million in 2025.
  • The last three reported values for Receivables - Other were $66.1 million (Q4 2025), $24.6 million (Q3 2025), and $52.6 million (Q2 2025) per Business Quant data.